Shoushtari, Alexander

Publications

Sort by

Co-Author Network

selected publications

Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Academic Article GET IT
Times cited: 144
Tolerance and efficacy of BRAF plus MEK inhibition in patients with melanoma who previously have received programmed cell death protein 1-based therapy. Cancer. 2018 Academic Article GET IT
Times cited: 44
Hepatic abnormalities identified by staging MRI and accuracy of MRI of patients with uveal melanoma. The British journal of ophthalmology. 2018 Academic Article GET IT
Times cited: 3
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor. Investigational new drugs. 2018 Academic Article GET IT
Times cited: 33
GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma. Cell reports. 2018 Academic Article GET IT
Times cited: 56
Peripheral blood clinical laboratory variables associated with outcomes following combination nivolumab and ipilimumab immunotherapy in melanoma. Cancer medicine. 2018 Academic Article GET IT
Times cited: 88
Clinical and Morphologic Characteristics of MEK Inhibitor-Associated Retinopathy: Differences from Central Serous Chorioretinopathy. Ophthalmology. 2017 Academic Article GET IT
Times cited: 101
An elderly man with remote history of metastatic melanoma now with localized pancreas cancer and new liver masses. 2017 GET IT
Patient perspectives on ipilimumab across the melanoma treatment trajectory. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017 Academic Article GET IT
Times cited: 19
Thinking Critically About Classifying Adverse Events: Incidence of Pancreatitis in Patients Treated With Nivolumab + Ipilimumab. Journal of the National Cancer Institute. 2016 Academic Article GET IT
Times cited: 56
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 107
Efficacy and Safety of Nivolumab Alone or in Combination With Ipilimumab in Patients With Mucosal Melanoma: A Pooled Analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 447
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies. Cancer. 2016 Academic Article GET IT
Times cited: 287
The efficacy of anti-PD-1 agents in acral and mucosal melanoma. Cancer. 2016 Academic Article GET IT
Times cited: 239
Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis. The oncologist. 2016 Academic Article GET IT
Times cited: 147
A phase 2 trial of everolimus and pasireotide long-acting release in patients with metastatic uveal melanoma. Melanoma research. 2016 Academic Article GET IT
Times cited: 33
Overall Survival and Response to Systemic Therapy in Metastatic Extrauterine Leiomyosarcoma. Sarcoma. 2016 Academic Article GET IT
Times cited: 10
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma. Nature genetics. 2016 Academic Article GET IT
Times cited: 224
Localized sinonasal mucosal melanoma: Outcomes and associations with stage, radiotherapy, and positron emission tomography response. Head & neck. 2016 Academic Article GET IT
Times cited: 69
Treatment of Uveal Melanoma. Cancer treatment and research. 2016 Article GET IT
Times cited: 13
Safety and efficacy of ipilimumab to treat advanced melanoma in the setting of liver transplantation. Journal for immunotherapy of cancer. 2015 Academic Article GET IT
Times cited: 94
GNAQ and GNA11 mutations in uveal melanoma. Melanoma research. 2014 Information Resource GET IT
Times cited: 66
Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment. Human pathology. 2014 Academic Article GET IT
Times cited: 240
A woman with metastatic pancreatic neuroendocrine tumor. Gastrointestinal cancer research : GCR. 2014 Academic Article GET IT
Novel treatment targets in sarcoma: more than just the GIST. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2014 Information Resource GET IT
Times cited: 5
Metastasis-suppressor genes in clinical practice: lost in translation?. Nature reviews. Clinical oncology. 2011 Information Resource GET IT
Times cited: 43
Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer research. 2009 Academic Article GET IT
Times cited: 140
Comparing genetically engineered mouse mammary cancer models with human breast cancer by expression profiling. Breast disease. 2007 Information Resource GET IT
Times cited: 12

more ...

less ...

Background

education and training

M.D., Rush Medical College 2009
B.S., Northwestern University 2004

Contact

full name

Alexander Shoushtari

VIVO Weill Cornell Medical College

Alexander Shoushtari Assistant Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name